Home › Quitting Smoking (Tobacco Use Disorder) › NCT07576595

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Effectiveness of a Multilevel Integrated Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Who can join

Ages 50 to 80 · All sexes

Inclusion Criteria:

* African American
* 20+ pack years of smoking
* eligible for or received LDCT screening
* current smoker
* English speaking

Exclusion Criteria:

* N/A

About the study

This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.

What is being tested

• Smoking cessation multilevel Intervention (behavioral)

Sponsor: Louisiana State University Health Sciences Center in New Orleans · Participants: 250 · Started: Apr 17, 2025

Contact the study team

• Jessica Kassner, MS, MPH · Phone: 504-568-5724

Official record on ClinicalTrials.gov — NCT07576595

Locations in the U.S.

Conditions

• Quitting Smoking (Tobacco Use Disorder)
• Quitting Smoking

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.